Chemodrug resistance: Cancer’s fight for survival

id	metarevistapublica_unicolmayor_nova_9-article-2278
record_format	ojs
spelling	Chemodrug resistance: Cancer’s fight for survival 21 Sandoval Cabrera, Antonio Martinez Quintero, Daniel Alejandro Santillán Benítez, Jonnathan Guadalupe REVISTA NOVA Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD Artículo de revista Alcántara Colin, Jafet Núm. 41 , Año 2023 : Julio-Diciembre de 2023 41 Journal article Xavier CPR, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, Vasconcelos MH. The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resist Updat. 2022 May;62:100833. doi: 10.1016/j.drup.2022.100833. Epub 2022 Apr 5. PMID: 35429792. Yang C, Zhang J, Ma Y, Wu C, Cui W, Wang L. Histone methyltransferase and drug resistance in cancers. J Exp Clin Cancer Res. 2020 Aug 28;39(1):173. doi: 10.1186/s13046- 020-01682-z. PMID: 32859239; PMCID: PMC7455899. LiX,LiM,HuangM,LinQ,FangQ,LiuJ,ChenX,Liu L,ZhanX,ShanH,LuD,LiQ,LiZ,ZhuX.Themulti- molecular mechanisms of tumor-targeted drug resistance in precision medicine. Biomed Pharmacother. 2022 Jun;150:113064. doi: 10.1016/j.biopha.2022.113064. Epub 2022 May 5. PMID: 35658234. Atlas de Proteínas Humanas [Internet]. [accessed March 31/2023]. Available in: https://www.proteinatlas.org/ About - STRING functional protein association networks [Internet]. [accessed Mrch 31/2023]. Available in:https:// stringdb.org/cgi/about?footer_active_subpage=statistics Jo H, Shim K, Jeoung D. Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. Int J Mol Sci. 2022 May 24;23(11):5881. doi: 10.3390/ ijms23115881. PMID: 35682560; PMCID: PMC9180509. MIR100 microARN 100 [Homo sapiens (human)] - Gen - NCBI [Internet]. [accessed March 31/2023]. Available in: https://www.ncbi.nlm.nih.gov/gene/406892 Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019 Feb 11;11(1):25. doi: 10.1186/s13148- 018-0587-8. PMID: 30744689; PMCID: PMC6371621. Song H, Liu D, Dong S, Zeng L, Wu Z, Zhao P, Zhang L, Chen ZS, Zou C. Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Target Ther. 2020 Sep 8;5(1):193. doi: 10.1038/s41392-020-00300-w. PMC7479143. Kwon Y, Kim Y, Jung HS, Jeoung D. Role of HDAC3- miRNA-CAGE Network in Anti-Cancer Drug-Resistance. Int J Mol Sci. 2018 Dec 23;20(1):51. doi: 10.3390/ ijms20010051. PMID: 30583572; PMCID: PMC6337380. De Las Rivas J, Brozovic A, Izraely S, Casas-Pais A, Witz IP, Figueroa A. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol. 2021 Jul;95(7):2279- 2297. doi: 10.1007/s00204-021-03063-7. Epub 2021 May 18. PMID: 34003341; PMCID: PMC8241801. Hillyar CR, Kanabar SS, Rallis KS, Varghese JS. Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironment. Epigenomics. 2022 Jun;14(11):699-709. doi: 10.2217/epi- 2021-0534. Epub 2022 May 16. PMID: 35574589. Namee NM, O’Driscoll L. Extracellular vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):123-136. doi: 10.1016/j. bbcan.2018.07.003. Epub 2018 Jul 10. PMID: 30003999. Asano T. Drug Resistance in Cancer Therapy and the Role of Epigenetics. J Nippon Med Sch. 2020 Dec 14;87(5):244- 251. doi: 10.1272/jnms.JNMS.2020_87-508. Epub 2020 May 30. PMID: 32475898. Definición de epigenética – Cancer dictionary [Internet]. [accessed March 31/2023]. Available in: https://www.cancer. gov/publications/dictionaries/cancer-terms/def/epigenetics Riddihough G, Zahn LM. Epigenetics. What is epigenetics? Introduction. Science. 2010 Oct29;330(6004):611. doi: 10.1126/science.330.6004.611. PMID: 21030643. Abdelaal MR, Haffez H. The potential roles of retinoids in combating drug resistance in cancer: implications of ATP- binding cassette (ABC) transporters. Open Biol. 2022 Jun;12(6):220001. doi: 10.1098/rsob.220001. Epub 2022 Jun 1. PMID: 35642494; PMCID: PMC9157304. Wu T, Gu X, Cui H. Emerging Roles of SKP2 in Cancer Drug Resistance. Cells. 2021 May 10;10(5):1147. doi: 10.3390/ cells10051147. PMID: 34068643; PMCID: PMC8150781. Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel JC. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 2019 Mar 30;18(1):55. doi: 10.1186/s12943-019-0965-7. PMID: 30925923; PMCID: PMC6441157. Xavier CPR, Caires HR, Barbosa MAG, Bergantim R, Guimarães JE, Vasconcelos MH. The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance. Cells. 2020 May 6;9(5):1141. doi: 10.3390/cells9051141. PMID: 32384712; PMCID: PMC7290603. Kwon Y, Kim M, Kim Y, Jung HS, Jeoung D. Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages. Front Immunol. 2020 Jun 11;11:1167. doi: 10.3389/fimmu.2020.01167. PMID: 32595638; PMCID: PMC7300210. Yao S, Fan LY, Lam EW. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance. Semin Cancer Biol. 2018 Jun;50:77-89. doi: 10.1016/j. semcancer.2017.11.018. Epub 2017 Nov 24. PMID: 29180117; PMCID: PMC6565931. Nwabo Kamdje AH, Seke Etet PF, Kipanyula MJ, Vecchio L, Tagne Simo R, Njamnshi AK, Lukong KE, Mimche PN. Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential. Front Endocrinol (Lausanne). 2022 Aug 9;13:927390. doi: 10.3389/fendo.2022.927390. PMID: 36017326; PMCID: PMC9395641. Yun CW, Kim HJ, Lim JH, Lee SH. Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy. Cells. 2019 Dec 24;9(1):60. doi: 10.3390/cells9010060. PMID: 31878360; PMCID: PMC7017199. Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, Fu L. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022 Jul 18;15(1):97. doi: 10.1186/s13045-022- 01313-4. PMID: 35851420; PMCID: PMC9290242. Text http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ARTREF http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article https://revistas.unicolmayor.edu.co/index.php/nova/article/download/2278/3189 Leonardo-Sousa C, Carvalho AN, Guedes RA, Fernandes PMP, Aniceto N, Salvador JAR, Gama MJ, Guedes RC. Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance. Molecules. 2022 Mar 28;27(7):2201. doi: 10.3390/ molecules27072201. PMID: 35408601; PMCID: PMC9000344. Zhang L, Wang D, Yang K, Sheng D, Tan B, Wang Z, Ran H, Yi H, Zhong Y, Lin H, Chen Y. Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation. Adv Sci (Weinh). 2018 May 21;5(8):1800049. doi: 10.1002/advs.201800049. PMID: 30128231; PMCID: PMC6097143. Yan L, Lin M, Pan S, Assaraf YG, Wang ZW, Zhu X. Emerging roles of F-box proteins in cancer drug resistance. Drug Resist Updat. 2020 Mar;49:100673. doi: 10.1016/j. drup.2019.100673. Epub 2019 Dec 17. PMID: 31877405. KarimiM,SahandiZangabadP,Baghaee-RavariS,Ghazadeh M, Mirshekari H, Hamblin MR. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light. J Am Chem Soc. 2017 Apr 5;139(13):4584-4610. doi: 10.1021/ jacs.6b08313. Epub 2017 Mar 13. PMID: 28192672; PMCID: PMC5475407. Cheng L, Wang C, Feng L, Yang K, Liu Z. Functional nanomaterials for phototherapies of cancer. Chem Rev. 2014 Nov 12;114(21):10869-939. doi: 10.1021/cr400532z. Epub 2014 Sep 26. PMID: 25260098. Sun X, Hu B. Mathematical modeling and computational prediction of cancer drug resistance. Brief Bioinform. 2018 Nov 27;19(6):1382-1399. doi: 10.1093/bib/bbx065. PMID: 28981626; PMCID: PMC6402530. Szumilak M, Wiktorowska-Owczarek A, Stanczak A. Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance? Molecules. 2021 Apr 29;26(9):2601. doi: 10.3390/molecules26092601. PMID: 33946916; PMCID: PMC8124695. SMPDB [Internet]. [accessed March 31/2023]. Available in: https://smpdb.ca/view?subject=Drug+Metabolism SunR,YingY,TangZ,LiuT,ShiF,LiH,GuoT,Huang S, Lai R. The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein Pept Lett. 2020;27(1):17-29. doi: 10.2174/0929866526666190926154248. 31556849; PMCID: PMC6978646. Bu L, Baba H, Yasuda T, Uchihara T, Ishimoto T. Functional diversity of cancer-associated fibroblasts in modulating drug resistance. Cancer Sci. 2020 Oct;111(10):3468-3477. doi: 10.1111/cas.14578. Epub 2020 Aug 11. PMID: 33044028; PMCID: PMC7541012. Saito RF, Andrade LNS, Bustos SO, Chammas R. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells. Front Immunol. 2022 Feb 15;13:768606. doi:10.3389/fimmu.2022.768606. PMID: 35250970; PMCID: PMC8889569. Gu L, Saha ST, Thomas J, Kaur M. Targeting cellular cholesterol for anticancer therapy. FEBS J. 2019 Nov;286(21):4192-4208. doi: 10.1111/febs.15018. Epub 2019 Aug 12. PMID: 31350867. Seo J, Ha J, Kang E, Cho S. The role of epithelial-mesenchymal transition-regulating transcription factors in anti-cancer drug resistance. Arch Pharm Res. 2021 Mar;44(3):281-292. doi: 10.1007/s12272-021-01321-x. Epub 2021 Mar 25. PMID: 33768509; PMCID: PMC8009775. Bhattacharya S, Mohanty A, Achuthan S, Kotnala S, Jolly MK, Kulkarni P, Salgia R. Group Behavior and Emergence of Cancer Drug Resistance. Trends Cancer. 2021 Apr;7(4):323- 334. doi: 10.1016/j.trecan.2021.01.009. Epub 2021 Feb 20. PMID: 33622644; PMCID: PMC8500356. Cao Y. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest. 2019 Jul 2;129(8):3006-3017. doi: 10.1172/JCI127201. PMID: 31264969; PMCID: PMC6668696. Kadel D, Zhang Y, Sun HR, Zhao Y, Dong QZ, Qin LX. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy. Cell Biol Toxicol. 2019 Oct;35(5):407-421. doi: 10.1007/s10565-019-09461-z. Epub 2019 Jan 24. PMID: 30680600; PMCID: PMC6881418. application/pdf Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. NOVA - 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/ https://doi.org/10.22490/24629448.7535 10.22490/24629448.7535 https://revistas.unicolmayor.edu.co/index.php/nova/article/view/2278 2462-9448 1794-2470 2023-12-16 Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020 May 2;21(9):3233. doi: 10.3390/ijms21093233. PMID: 32370233; PMCID: PMC7247559. 2023-12-16 00:00:00 2023-12-16 00:00:00 cytochrome P450 chemoresistance resistance cancer Cytochrome P450 chemoresistance resistance cancer Cáncer hoy [Internet]. [accessed 31 de marzo de 2023]. Available: https://gco.iarc.fr/today/about Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019 Jun;20(6):769-780. doi: 10.1016/S1470-2045(19)30163- 9. Epub 2019 May 8. Erratum in: Lancet Oncol. 2019 Jul;20(7):e346. PMID: 31078462. Yoo HC, Han JM. Amino Acid Metabolism in Cancer Drug Resistance. Cells. 2022 Jan 2;11(1):140. doi: 10.3390/ cells11010140. PMID: 35011702; PMCID: PMC8750102. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version - NCI [Internet]. [accessed March 31/2023 ]. Available in: https://www.cancer.gov/types/ leukemia/patient/child-all-treatment-pdq Crettol S, Petrovic N, Murray M. Pharmacogenetics of phase I and phase II drug metabolism. Curr Pharm Des. 2010;16(2):204-19. doi: 10.2174/138161210790112674. PMID: 19835560. Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: An update and perspective. Drug Resist Updat. 2021 Dec;59:100796. doi: 10.1016/j.drup.2021.100796. Epub 2021 Dec 16. PMID: 34953682; PMCID: PMC8810687. Konieczkowski DJ, Johannessen CM, Garraway LA. A Convergence-Based Framework for Cancer Drug Resistance. Cancer Cell. 2018 May 14;33(5):801-815. doi: 10.1016/j.ccell.2018.03.025. PMID: 29763622; PMCID: PMC5957297. Chatterjee N, Bivona TG. Polytherapy and Targeted Cancer Drug Resistance. Trends Cancer. 2019 Mar;5(3):170-182. doi: 10.1016/j.trecan.2019.02.003. Epub 2019 Feb 26. PMID: 30898264; PMCID: PMC6446041. Leighow SM, Liu C, Inam H, Zhao B, Pritchard JR. Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug Design. Cell Rep. 2020 Mar 24;30(12):3951-3963.e4. doi: 10.1016/j. celrep.2020.02.108. PMID: 32209458; PMCID: PMC8000225. Rocha CRR, Silva MM, Quinet A, Cabral-Neto JB, Menck CFM. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics (Sao Paulo). 2018 Sep 6;73(suppl 1):e478s. doi: 10.6061/clinics/2018/e478s. PMID: 30208165; PMCID: PMC6113849. Mills JN, Rutkovsky AC, Giordano A. Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors. Curr Opin Pharmacol. 2018 Aug;41:59-65. doi: 10.1016/j. coph.2018.04.009. Epub 2018 Apr 30. PMID: 29719270; PMCID: PMC6454890. Tamoxifeno \| C26H29NO - PubChem [Internet]. [accessed March 31/2023]. Available in: https://pubchem.ncbi.nlm. nih.gov/compound/2733526 Penning TM, Jonnalagadda S, Trippier PC, Rižner TL. Aldo-Keto Reductases and Cancer Drug Resistance. Pharmacol Rev. 2021 Jul;73(3):1150-1171. doi: 10.1124/ pharmrev.120.000122. PMID: 34312303; PMCID: PMC8318518. Olivas-Aguirre M, Torres-López L, Pottosin I, Dobrovinskaya O. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol. Front Oncol. 2021 Mar 11;11:617937. doi: 10.3389/fonc.2021.617937. PMID: 33777761; PMCID: PMC7991804. Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2019;2(2):141- 160. doi: 10.20517/cdr.2019.10. Epub 2019 Jun 19. PMID: 34322663; PMCID: PMC8315569. Goldman M, Velu T, Pretolani M. Interleukin-10: actions and therapeutic potential. BioDrugs. 1997 Jan;7(1):6- 14. doi: 10.2165/00063030-199707010-00002. PMID: 18031075. WELCH AD. The problem of drug resistance in cancer chemotherapy. Cancer Res. 1959 May;19(4):359-71. PMID: 13652119. SCHERER WF, SYVERTON JT, GEY GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953 May;97(5):695- 710. doi: 10.1084/jem.97.5.695. PMID: 13052828; PMCID: PMC2136303. 1DE LA TORRE MORALI M. El tratamiento del cancer por agentes químicos [Cancer treatment by chemical agents]. Prog Med Rev Asoc Med Latinoam. 1945 Nov-Dec;6:18-24. Spanish. PMID: 20986277. Akatsu S, Noguchi H.the drug-fastness of spirochetes to arsenic, mercurial, and iodide compounds in vitro. J Exp Med. 1917 Mar 1;25(3):349-62. doi: 10.1084/jem.25.3.349. PMID: 19868093; PMCID: PMC2125488. De las cadenas laterales a la radioterapia de diana [Internet]. [accessed March 31/2023]. Available in: http:// scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 084X2016000100009 García-Sánchez JE, García E, Lucila Merino M. Cien años de la bala mágica del Dr. Ehrlich (1909–2009). Enferm Infecc Microbiol Clin. el 1 de octubre de 2010;28(8):521–33. DOI: 10.1016/j.eimc.2009.07.009 LOURIE EM. A sketch of the history of chemotherapy. Br Med Bull. 1946;4(4):243-8. doi: 10.1093/oxfordjournals. bmb.a072785. PMID: 20281774. Definición de resistencia a los medicamentos - Diccionario de cáncer del NCI - NCI [Internet]. [accessed March 31/2023]. Available in : https://www.cancer.gov/publications/ dictionaries/cancer-terms/def/drug-resistance Sritharan S, Sivalingam N. A comprehensive review on time- tested anticancer drug doxorubicin. Life Sci. 2021 Aug 1; 278:119527. doi:10.1016/j.lfs.2021.119527. Epub 2021 Apr 20. PMID: 33887349. Publication
institution	UNIVERSIDAD COLEGIO MAYOR DE CUNDINAMARCA
thumbnail	https://nuevo.metarevistas.org/UNIVERSIDADCOLEGIOMAYORDECUNDINAMARCA/logo.png
country_str	Colombia
collection	NOVA
title	Chemodrug resistance: Cancer’s fight for survival
spellingShingle	Chemodrug resistance: Cancer’s fight for survival Sandoval Cabrera, Antonio Martinez Quintero, Daniel Alejandro Santillán Benítez, Jonnathan Guadalupe Alcántara Colin, Jafet cytochrome P450 chemoresistance resistance cancer Cytochrome P450 chemoresistance resistance cancer
title_short	Chemodrug resistance: Cancer’s fight for survival
title_full	Chemodrug resistance: Cancer’s fight for survival
title_fullStr	Chemodrug resistance: Cancer’s fight for survival
title_full_unstemmed	Chemodrug resistance: Cancer’s fight for survival
title_sort	chemodrug resistance: cancer’s fight for survival
author	Sandoval Cabrera, Antonio Martinez Quintero, Daniel Alejandro Santillán Benítez, Jonnathan Guadalupe Alcántara Colin, Jafet
author_facet	Sandoval Cabrera, Antonio Martinez Quintero, Daniel Alejandro Santillán Benítez, Jonnathan Guadalupe Alcántara Colin, Jafet
topic	cytochrome P450 chemoresistance resistance cancer Cytochrome P450 chemoresistance resistance cancer
topic_facet	cytochrome P450 chemoresistance resistance cancer Cytochrome P450 chemoresistance resistance cancer
citationvolume	21
citationissue	41
citationedition	Núm. 41 , Año 2023 : Julio-Diciembre de 2023
publisher	Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD
ispartofjournal	REVISTA NOVA
source	https://revistas.unicolmayor.edu.co/index.php/nova/article/view/2278
language
format	Article
rights	http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. NOVA - 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2023-12-16
date_accessioned	2023-12-16 00:00:00
date_available	2023-12-16 00:00:00
url	https://revistas.unicolmayor.edu.co/index.php/nova/article/view/2278
url_doi	https://doi.org/10.22490/24629448.7535
issn	1794-2470
eissn	2462-9448
doi	10.22490/24629448.7535
url2_str_mv	https://revistas.unicolmayor.edu.co/index.php/nova/article/download/2278/3189
_version_	1815767162788249600

Chemodrug resistance: Cancer’s fight for survival .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Chemodrug resistance: Cancer’s fight for survival
.